Nucleus Network on the frontline against COVID-19

Nucleus Network CEO Cameron Johnson and Chief Medical Officer (CMO) Dr. Jason Lickliter spoke to the Victorian Chamber of Commerce and Industry about our efforts in the development of a vaccine for COVID-19.

They also discuss the unique advantages of conducting Phase 1 clinical trials in Australia, especially during these unprecedented times.